24-002053

Submitted by fratecm on
Post Date/ Solicitation Issue Date
Closing Response Date
Proposed Award Date
Project Title
Polysmongraphy/Home sleep study device
Contracting Office
National Institute of Mental Health (NIMH)

Contact Points

Primary Contract Specialist

Cheryl
Leone
cleone@mail.nih.gov

Secondary Contracting Officer

Dionne
Draper
dionne.draper@nih.gov
NAICS Code Number
621512
Diagnostic Imaging
Small Business Size Standard
$19,000,000
FPDS Classification Code
6515
Estimated Period of Performance
approximately 3 months for training to be completed
Delivery of Goods
30 days ARO
Set-Aside Status
Full Set Aside
Set-Aside Type
Small Business (SB)
Competition Status
Non-Competitive
Vendor Name
Nox Medical/ARC Holding
Vendor Address
6485 Shiloh Rd, BLDG B, STE 500
Alpharetta, Georgia 30005
Single-Sole Source Determination
The essential characteristics of the NOX Medical – A1 device that limit the availability to a sole source are proprietary engineering and software which has been patented. Only this suggested source can furnish the requirements, to the exclusion of other sources, because NOX Medical is the sole distributor in the USA.

A patent, copyright, proprietary data, or licensing agreement limits competition. The proprietary data are described as NOX Medical
Any other facts supporting the justification. Future protocols currently onboarding, will require the NOX Medical A1 with it’s specific and unique features.
Background/Description of Requirement

 

  1. Background Information and Objective: 
    • The Sleep and Neurodevelopment Service investigates neurophysiological sleep signatures that characterize diverse developmental trajectories. This project aims to investigate neurophysiological sleep signatures that can elucidate trajectories of the interaction between clinically disturbed sleep and a specific re-experiencing symptom – intrusive memories – that characterizes PTSD in response to an intervention that is proposed to affect both sleep and re-experiencing. Sleep is essential for the optimal functioning of the body and mind and its disruption is linked to numerous physical, neurological, and mental health conditions. Sleep disruption has been proposed as a critical component of PTSD symptomatology, and sleep disorders, in particular insomnia, nightmare disorder, and obstructive sleep apnea, have been found to be highly comorbid with PTSD, with higher prevalence rates of these disorders than in the general population. Sleep abnormalities in PTSD include alterations in the time spent in particular sleep stages, total sleep time, sleep latency, time awake after sleep onset, and in neural oscillations during sleep. In this study, our objective is to investigate the effects of a meditation intervention on sleep components (specifically sleep stage percentage, wake after sleep onset time, spectral power of neural oscillations during REM and slow wave sleep, and sleep spindle oscillations) in this population. The results of this study and information related to the feasibility of protocol implementation will inform the development of a similar study that will investigate the development of PTSD symptoms in first responders after exposure to trauma, as well as the effectiveness of this meditation intervention as an early preventative of the development of PTSD symptoms and sleep disturbances.
    1. Salient characteristics The Nox A1s is a small and lightweight PSG device that shows reliable, high-quality signals, and is designed for an easy hookup experience and patient comfort. The Nox A1s PSG System has dual-purpose flexibility for in-lab and ambulatory sleep studies.

 

  1. Salient characteristics The Nox A1s is a small and lightweight PSG device that shows reliable, high-quality signals, and is designed for an easy hookup experience and patient comfort. The Nox A1s PSG System has dual-purpose flexibility for in-lab and ambulatory sleep studies.

572010 Live Web Training 4 hours of live virtual training

513113 Nox A1s System with SpO2, US Nox A1s full AASM PSG sleep system with both in lab and ambulatory capabilities. Includes integrated EEG, EMG, EOG, EKG, calibrated RIP, PTAF, and body position 1

554020 Nox Snap-on Lead 50 cm, White 2

554209 BlueSensor N Electrode (Small) Pack of 25 8 

555020 Ten20 Conductive EEG Paste 1 

555010 Nuprep Skin Prep Gel 3 

555031 Tensive Conductive Adhesive Gel 1 

548016 PC Computer HP ProDesk 400 G5 Mini Desktop PC 1 

548017 Computer Monitor BenQ GW2780 27" Full HD 1920 x 1080 5ms Built-in Speakers Low Blue Light Flicker-Free Backlit LED IPS Monitor 1 

553910 WristOx2 3150 Sensor Adapter Cable Pack of 1 pcs 1

552230 Thermal Flow Sensor, Reusable (Adult) 1 

554210 BlueSensor M Electrode Pack of 50 pcs 6 

553130 Flex Sensor with flexiwraps, Adult Pack of 1 with 25 Flexi Wraps 1 

 

 

 

Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.

All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.